Masulli, M.
Federico II University Hospital · University of Naples Federico II
3 papers on CoChatORCID 0000-0002-7848-6456
Most cited papers
- Verified
Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial
Della Pepa, G., Russo, M., Vitale, M., Carli, F., Vetrani, C., Masulli, M., Riccardi, G., Vaccaro, O., Gastaldelli, A., Rivellese, A. A., et al. (2021) · Diabetes Research and Clinical Practice
Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management
Cited by 84
- Verified
Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low-grade inflammation in patients with type 2 diabetes—The TOSCA.IT Study
Vitale, M., Masulli, M., Rivellese, A. A., Babini, A. C., Boemi, M., Bonora, E., Buzzetti, R., Ciano, O., Cignarelli, M., Cigolini, M., et al. (2016) · European Journal of Nutrition
Nutritional Studies and DietDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 60
- Verified · note
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study
on behalf of the TOSCA.IT Study Group, Vitale, M., Masulli, M., Rivellese, A. A., Bonora, E., Cappellini, F., Nicolucci, A., Squatrito, S., Antenucci, D., Barrea, A., et al. (2018) · European Journal of Nutrition
Phytochemicals and Antioxidant ActivitiesNutritional Studies and Diet
Cited by 56
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free